摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[7-(2,4-Dimethylpiperazin-1-yl)-2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidin-9-yl]-1,3-oxazinan-2-one | 1251462-42-6

中文名称
——
中文别名
——
英文名称
3-[7-(2,4-Dimethylpiperazin-1-yl)-2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidin-9-yl]-1,3-oxazinan-2-one
英文别名
3-[7-(2,4-dimethylpiperazin-1-yl)-2-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-3-hydroxy-4-oxopyrido[1,2-a]pyrimidin-9-yl]-1,3-oxazinan-2-one
3-[7-(2,4-Dimethylpiperazin-1-yl)-2-[5-[(4-fluorophenyl)methyl]thiazol-2-yl]-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidin-9-yl]-1,3-oxazinan-2-one化学式
CAS
1251462-42-6
化学式
C28H29FN6O4S
mdl
——
分子量
564.64
InChiKey
OCXNURLGADLXON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    40
  • 可旋转键数:
    5
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    130
  • 氢给体数:
    1
  • 氢受体数:
    10

反应信息

  • 作为产物:
    参考文献:
    名称:
    Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
    摘要:
    A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported. Initial SAR studies revealed that activities against wild-type virus were successfully maintained at single digit nanomolar level with a wide range of substitutions. However, inclusion of nitrogen-based cyclic substitutions was crucial for achieving potency against mutant viruses. Several compounds with excellent activities against wild-type virus as well as against the viruses with the mutations Q148H/G140S or N155H/E92Q were reported. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.041
点击查看最新优质反应信息

文献信息

  • Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
    作者:Giang Le、Nick Vandegraaff、David I. Rhodes、Eric D. Jones、Jonathan A.V. Coates、Long Lu、Xinming Li、Changjiang Yu、Xiao Feng、John J. Deadman
    DOI:10.1016/j.bmcl.2010.07.041
    日期:2010.9
    A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported. Initial SAR studies revealed that activities against wild-type virus were successfully maintained at single digit nanomolar level with a wide range of substitutions. However, inclusion of nitrogen-based cyclic substitutions was crucial for achieving potency against mutant viruses. Several compounds with excellent activities against wild-type virus as well as against the viruses with the mutations Q148H/G140S or N155H/E92Q were reported. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多